From FDA approvals to medical milestones, here are four key developments from spine and orthopedic medtech companies since Jan. 29.

Learn more about whether Edwards Lifesciences Corporation or Stryker Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Just one month into 2025, a handful of stocks have already generated some massive gains. Top 2025 performers include several ...

Europe medical device market was valued at $144.4 billion in 2022 and will grow by 4.7% annually over 2022-2032, driven by the prevalence of infectious diseases as well as the increasing prevalence of ...

North America medical device market is projected to grow by 3.9% annually in the forecast period and reach $ 282.3 billion by 2032, driven by the prevalence of infectious diseases as well as the ...

The department announced Friday that they'll be adding $1.1 million in new equipment for the first time since 2017. The ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/19.CwRXVpI-.js ...

Medical technology company Stryker (NYSE:SYK) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales ...

What Happened: Pierce, Group President at Stryker, made a strategic move by exercising stock options for 9,455 shares of SYK as detailed in a Form 4 filing on Thursday with the U.S. Securities and ...

The Friday morning market activity shows Stryker shares up by 0.87%, trading at $393.83. This implies a total value of $3,070,887 for Stiles's 10,210 shares.